Management of lung cancer patients' quality of life in clinical practice: a Delphi study
Affiliation auteurs | !!!! Error affiliation !!!! |
Titre | Management of lung cancer patients' quality of life in clinical practice: a Delphi study |
Type de publication | Journal Article |
Year of Publication | 2021 |
Auteurs | Westeel V., Bourdon M., Cortot A.B, Debieuvre D., Toffart A.-C, Acquadro M., Arnould B., Lambert J., Cotte F.-E, Gaudin A.-F, Lemasson H. |
Journal | ESMO OPEN |
Volume | 6 |
Pagination | 100239 |
Date Published | AUG |
Type of Article | Article |
Mots-clés | Clinical practice, Delphi study, Lung cancer, Quality of life |
Résumé | Background: The assessment of health-related quality of life (HRQoL) has seen exponential growth in oncology clinical trials. However, the measurement of HRQoL has yet to be optimised in routine clinical practice. This study aimed at exploring the operationalisation of HRQoL in clinical practice with the goal of reaching a consensus from a panel of physicians. Materials and methods: Physicians involved in the management of lung cancer patients in France were recruited to participate in a Delphi study. The study involved three rounds of iterated queries to gain consensus on management aspects of HRQoL, including timing of discussion on HRQoL, which specific domains of HRQoL should be discussed, and what was the most appropriate method of assessment. The threshold adopted for consensus was at least 70% agreement among physicians. A scientific committee reviewed results following each round of the Delphi study. Results: A representative panel of 60 physicians participated in this study. Consensus was obtained for HRQoL management at all time points in the patient care pathway. Panellists agreed that HRQoL discussions should occur during routine visits and hospitalisation. The involvement of patients' relatives was also recognised as important, except when discussing side-effects and involvement of a multidisciplinary team. There was a lack of consensus on a systematic assessment for all patients at each visit and no consensus on how HRQoL should be measured in clinical practice. Conclusions: HRQoL discussions are considered an integral part in the management of lung cancer patients, and are deemed key to success in patientephysician interaction. Further research is required to harmonise how best to implement HRQoL assessment. |
DOI | 10.1016/j.esmoop.2021.100239 |